Healthy Living Arizona
SEE OTHER BRANDS

Following health and wellness news from Arizona

Healthy Living Arizona: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.

Press releases published on August 25, 2025

ReGen Advanced Infusion & Wellness to Host Educational Event at Strive PT in Chandler

ReGen Advanced Infusion & Wellness to Host Educational Event at Strive PT in Chandler

The community event will highlight regenerative medicine therapies for recovery, performance, and injury prevention. CHANDLER, AZ, UNITED STATES, August 25, 2025 /⁨EINPresswire.com⁩/ -- ReGen Advanced Infusion …

Mold Exposure: Updated Guidance Clarifies Risks and Misconceptions

Mold Exposure: Updated Guidance Clarifies Risks and Misconceptions

ACMT issues updated guidance on indoor mold exposure, clarifying health risks, dispelling mycotoxin myths, and warning against unproven tests and treatments. PHOENIX, AZ, UNITED STATES, August 25, 2025 /⁨EINPresswire.com⁩/ -- The American College of …

Walgreens Laly Havern, PharmD, BCACP, Joins Learn Look Locate to Lead Fertility Preservation Education in Breast Cancer

Walgreens Laly Havern, PharmD, BCACP, Joins Learn Look Locate to Lead Fertility Preservation Education in Breast Cancer

Walgreens oncofertility leader Laly Havern expands specialty pharmacy resources and advances global breast cancer education with Learn Look Locate. TUCSON, AZ, UNITED STATES, August 25, 2025 /⁨EINPresswire.com⁩/ -- Learn Look Locate—the world’s only …

Pranic Healer Gary Smith of Grateful Violet Recently Featured on Close Up Radio

Pranic Healer Gary Smith of Grateful Violet Recently Featured on Close Up Radio

TUCSON, AZ, UNITED STATES, August 25, 2025 /⁨EINPresswire.com⁩/ -- Grateful Violet, a new enterprise founded by healer Gary Smith, is proud to announce the launch of its diverse range of pranic healing sessions and workshops. With a vision to share the …

Hydreight Achieves 33% YoY H1 Revenue Growth, Records 3rd Consecutive Quarter of Profitability, and Strengthens Performance Across Verticals

Hydreight Achieves 33% YoY H1 Revenue Growth, Records 3rd Consecutive Quarter of Profitability, and Strengthens Performance Across Verticals

“We had a great first 6 months, with 33% year-over-year growth. We have also exceeded our internal metrics across all verticals in the first seven months of the year, reinforcing the strength of our strategy. A key focus has been our investment in making …

ANI Pharmaceuticals to Present at Upcoming Investor Conferences

ANI Pharmaceuticals to Present at Upcoming Investor Conferences

PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team …

Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway

Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway

- U.S. IND filing planned for Q4 2025 with U.S. enrollment expected to start in Q1 2026 - Patient dosing expected to begin in Australia in Q4 2025 HUNTSVILLE, AL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), …

Memgen Announces First Patient Dosed in Phase 1 Combination Cohort of MEM-288 Plus Docetaxel in Advanced Non–Small Cell Lung Cancer

Memgen Announces First Patient Dosed in Phase 1 Combination Cohort of MEM-288 Plus Docetaxel in Advanced Non–Small Cell Lung Cancer

TAMPA, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Memgen, Inc., a clinical-stage biotechnology company developing oncolytic immunotherapy for solid tumors, today announced the dosing of the first patient in its Phase 1 combination cohort evaluating …

Option Care Health To Participate in Upcoming Investor Conferences

Option Care Health To Participate in Upcoming Investor Conferences

BANNOCKBURN, Ill., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the following upcoming investor …

Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025

Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025

SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases …

RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference

RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference

ALISO VIEJO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in …

OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors

OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors

WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to …

Kyverna Therapeutics to Present at Upcoming Investor Conferences in September

Kyverna Therapeutics to Present at Upcoming Investor Conferences in September

EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, …

Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline

Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline

BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system (CNS) disorders, today announced its participation in the …

Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025

Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025

MP0533 data presented at European Hematology Association (EHA) highlights improved response rates and antitumor activity in low disease burden patients; additional data under amended dosing scheme expected in Q4 2025 IND filing on first radio-DARPin …

Over 2,000 Successful Surgeries for Drug-Resistant Epilepsy

Over 2,000 Successful Surgeries for Drug-Resistant Epilepsy

RIYADH, Saudi Arabia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …

Tevogen Sees Continued Growth in Institutional Ownership in Q2 2025; 72% of Holders Increased or Maintained Positions

Tevogen Sees Continued Growth in Institutional Ownership in Q2 2025; 72% of Holders Increased or Maintained Positions

WARREN, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding common stock, as reported by institutional investment …

Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight

Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight

New York, USA, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Non-cystic Fibrosis Bronchiectasis Market Ready to Shift Gears with the Entry of First DPP1 Blocker | DelveInsight Insmed’s BRINSUPRI (brensocatib) has reached a significant regulatory milestone, earning FDA …

UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences

UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences

WELLESLEY HILLS, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that members of its executive team will participate in …

Dr. Wade Newman Grant for Healthcare Students Opens Applications to Support Future Leaders in Medicine and Allied Health

Dr. Wade Newman Grant for Healthcare Students Opens Applications to Support Future Leaders in Medicine and Allied Health

BELLEFONTE, Pa., Aug. 25, 2025 (GLOBE NEWSWIRE) -- The Dr. Wade Newman Grant for Healthcare Students is now officially open for applications, offering undergraduate students pursuing careers in healthcare the opportunity to gain meaningful financial …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions